- Home
- ASTC vs KZIA Comparison
ASTC vs KZIA Comparison
Compare ASTC & KZIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASTC
- KZIA
- Stock Information
- Founded
- ASTC 1984
- KZIA 1994
- Country
- ASTC United States
- KZIA Australia
- Employees
- ASTC N/A
- KZIA N/A
- Industry
- ASTC Biotechnology: Laboratory Analytical Instruments
- KZIA Biotechnology: Pharmaceutical Preparations
- Sector
- ASTC Industrials
- KZIA Health Care
- Exchange
- ASTC Nasdaq
- KZIA Nasdaq
- Market Cap
- ASTC 8.6M
- KZIA 9.0M
- IPO Year
- ASTC 1995
- KZIA 1999
- Fundamental
- Price
- ASTC $4.87
- KZIA $8.01
- Analyst Decision
- ASTC
- KZIA Strong Buy
- Analyst Count
- ASTC 0
- KZIA 2
- Target Price
- ASTC N/A
- KZIA $14.00
- AVG Volume (30 Days)
- ASTC 6.3K
- KZIA 137.6K
- Earning Date
- ASTC 11-11-2025
- KZIA 11-14-2025
- Dividend Yield
- ASTC N/A
- KZIA N/A
- EPS Growth
- ASTC N/A
- KZIA N/A
- EPS
- ASTC N/A
- KZIA N/A
- Revenue
- ASTC $903,000.00
- KZIA $1,549,158.00
- Revenue This Year
- ASTC N/A
- KZIA N/A
- Revenue Next Year
- ASTC N/A
- KZIA $49.25
- P/E Ratio
- ASTC N/A
- KZIA N/A
- Revenue Growth
- ASTC N/A
- KZIA 248983.08
- 52 Week Low
- ASTC $4.71
- KZIA $2.86
- 52 Week High
- ASTC $8.52
- KZIA $39.05
- Technical
- Relative Strength Index (RSI)
- ASTC 41.36
- KZIA 49.61
- Support Level
- ASTC $4.85
- KZIA $7.60
- Resistance Level
- ASTC $5.25
- KZIA $8.88
- Average True Range (ATR)
- ASTC 0.17
- KZIA 0.53
- MACD
- ASTC 0.00
- KZIA 0.04
- Stochastic Oscillator
- ASTC 3.77
- KZIA 36.03
About ASTC Astrotech Corporation (DE)
Astrotech Corp is a science and technology development company. The firm invents, acquires, and commercializes technological innovations sourced from internal research, universities, laboratories, and research institutions. The 1st Detect develops, manufactures, and sells chemical analyzers for use in the airport security, military, and breath analysis markets. AgLAB develops a series of mass spectrometers for use in the agriculture market.
About KZIA Kazia Therapeutics Limited
Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing anti-cancer drugs. The group is developing paxalisib, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. The company is also developing EVT801 for the treatment of various tumors. Maximum of revenue is earned from South Korea.